Macrocyclic RGD-peptides with high selectivity for α v β 3 integrin in cancer imaging and therapy
RSC Medicinal Chemistry · 2025 · 16 (7) · 3077-3083
DOI: 10.1039/d5md00280j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Xiaozhong Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carbohydrate Chemistry & Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University Wuxi 214122 China zwu@j…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Funds for the Central Universities, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
We developed a novel macrocyclic RGD-peptides (2-c) with high selectivity for α v β 3 Integrin in specific tumor imaging and therapy via one-pot Srt A-mediated on-resin in situ cyclization strategy.
Autor:innen und Institutionen
- Key Laboratory of Carbohydrate Chemistry & Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University Wuxi 214122 China zwu@jiangnan.edu.cn.
- School of Biological and Food Engineering, Hefei Normal University Hefei 230601 China.
ORCID-Profile: Zhifang Zhou, Zhimeng Wu
Förderung
- Fundamental Research Funds for the Central Universities
- Higher Education Discipline Innovation Project
Zitieren
APA
Cheng, X., Li, C., Hong, H., Zhou, Z., & Wu, Z. (2025). Macrocyclic RGD-peptides with high selectivity for α v β 3 integrin in cancer imaging and therapy. RSC Medicinal Chemistry, 16(7), 3077-3083. https://doi.org/10.1039/d5md00280j
Vancouver
Cheng X, Li C, Hong H, Zhou Z, Wu Z. Macrocyclic RGD-peptides with high selectivity for α v β 3 integrin in cancer imaging and therapy. RSC Medicinal Chemistry. 2025;16(7):3077-3083. doi:10.1039/d5md00280j
BibTeX
@article{Cheng2025,
author = {Cheng, Xiaozhong and Li, Chen and Hong, Haofei and Zhou, Zhifang and Wu, Zhimeng},
title = {Macrocyclic RGD-peptides with high selectivity for α v β 3 integrin in cancer imaging and therapy},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {7},
pages = {3077--3083},
doi = {10.1039/d5md00280j}
}
EUVIMED